Both eicosapentaenoic acid (10:5n-3, EPA) and docosahexaenoic acid (22:6, DHA) can markedly lower plasma triglycerides and VLDL concentrations, linoleic acid and linolenic acid do not show the same effect at comparable doses. Moderate intakes of EPA and DHA increase HDL2 cholesterol but high intakes decrease HDL cholesterol.
As little as 1-2 g EPA and DHA (an amount equivalent to 100 g oily fish/day) can bring about a substantial reduction in plasma triglycerides in both normal and hypertriglyceridaemic patients. VLDL synthesis is decreased by moderate intakes and at high intakes (> 20 g n-3 fatty acids/day) LDL synthesis is also decreased. However, as with other triglyceride lowering agents such as fibrates, LDL levels tend to increase in patients with type IV and V hyperlipoproteinaemias. This may be a consequence of a reduction in VLDL particle size thus favouring the conversion of VLDL to LDL. EPA and DHA concentrates are not useful for the management of hypercholesterolaemia but are effective triglyceride lowering agents in patients with high levels ofVLDL and intermediate denisity lipoprotein. Animal studies show a synergistic LDL lowering effect of fish oil and the statins. High intakes of EPA and DHA may impair glucose homeostasis in non-insulin dependent diabetics and increase the requirement ofanti-oxidant nutrients in particular vitamin E. The latter may well be important in view ofthe knowledge the oxidative modification of low density lipoproteins is necessary for foam cell formation, an early event in the initiation of atherosclerosis.
The last speaker of the meeting was Professor James Shepherd (Glasgow) who addressed the
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Long-term parenteral nutrition: problems with venous access
It has long been recognized that parenteral nutrition can cause thrombosis in a relevant central vein, and Dr McIntyre (June 1990 JRSM, 371) correctly concludes that early referral to specialist centres is appropriate. Thrombosis may be a larger problem however than we realize.
The clinical diagnosis rate of 10-20% for thrombosis in association with central hyperalimentation may greatly underestimate its true incidence':". An incidence of 40-60%, found when routine contrast phlebography is used, makes thrombosis the most frequent complication of total parenteral nutrition (TPN). Wakefield" found that TPN solutions induce thrombogenicity by increasing the monocyte procoagulant activity both in vivo and in vitro.
problems of the economics of lipid lowering drug therapy. Although a number of intervention studies have established the clinical benefits of hypocholesterolaemic drug therapy, practical considerations dictate that these must be weighed against the costs of treatment, particularly since by consensus, up to 25% of the UK population may prove to be technically eligible for lipid lowering interventions.
In order to evaluate this problem, it is necessary to balance the costs of preventive therapy against the economic detractions associated with unchecked morbidity and mortality from heart disease. The latter has risen steadily by more than 10% per annum and currently exceeds £500 million to the NHS in England and Wales alone. Consideration of data accumulated by the Officeof Health Economics makes it clear that premature CHD deaths incur substantive additional economic burden to the community, in terms of lost productivity, increasing the economic attractiveness of supporting a CHD intervention and prevention programme.
Maximum benefit would accrue if the latter were targeted at young men with significantly elevated blood cholesterol levels who are exposed to additional coronary risk factors like diabetes mellitus, hypertension or cigarette smoking. The newly introduced potent HMG CoA reductase inhibitors make treatment of individuals with established coronary heart disease a particularly attractive proposition.
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Such enhanced monocyte procoagulant activity may be associated with intravascular thrombosis, and importantly in vitro at least, TPN solutions (20% dextrose, 10% amino acid solutions) may also induce endothelial cell procoagulant activity".
The procoagulant pathway is complex? but in essence is a T helper cell stimulated lymphokine mediated event where monocytes/macrophages are induced to synthesis and express on their cell surface, procoagulant activity. Inflammatory cytokines may then stimulate vascular endothelium similarly.
Two possible therapeutic modalities have been described. Firstly prostaglandin El and E2 have been successful in fulminant hepatitis in mice and men by blocking the monocyte/macrophage procoagulant activity8.9, and the concomitant use of lipid emulsion in the TPN regimen'", may also be helpful. of the heart.' Blair recovered consciousness in an hour and walked home within four", The recommended use by the Royal Humane Society in 1774 of mouth-to-mouth respiration (with the other measures as stated by Dr Griffin) was superseded in 1782 by the promotion of bellows instead". Yet even this idea did not last long, for within 50 years the Society had only warmth and rubbing left on their list of recommendations. ROBERT For many years I have found in the occult sciences rich sources of diagnosis and healing, but I do not think that the same criteria can be applied to them as to orthodox scientific experimentation. A palmist can often see clearly what has happened in the past by the strengths and weaknesses of the lines in the palm, and if there is a long clear lifeline he can predict longevity. But in many instances the future is not so easy to determine because there may be a break in a lifeline to show that a certain phase of existence has come to end, or else there may be a blurring and faintness due to illness. A period of crisis may well be indicated but often the life of the individual continues and the markings of the palm go on developing.
So, although I welcome the orthodox medical practitioners' willingness to move towards a more hol i stĩ and psychodiagnostic approach to patients, I am disturbed at the prospect that evidence collected from dead people's hands might be used to measure the potential for recovery of the living with all the psychological trauma that such predictions might bring. S LEWIS
